Streetbeat News

Products Services

CREX

Creative Realities, Inc. (NASDAQ:CREX) has expanded its partnership with Target Center to upgrade the arena's digital signage technology. The upgrade will include software, displays, video walls, and content creation design and optimization strategy. The rollout is planned for the 2023-2024 NBA season. This partnership is part of Creative Realities' continued expansion in the sports and entertainment sector.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:12 pm

ILMN

MYGN

Myriad Genetics and Illumina have achieved two key milestones in their strategic partnership aimed at advancing genomic profiling and homologous recombination deficiency (HRD) testing. The first milestone qualifies Myriad to conduct prospective clinical trial testing with an investigational use only test based off of Illumina's in-development IVD solution. The second milestone involves Myriad's initiation of its first reproducibility test project to support future regulatory filings.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:08 pm

NRSN

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) has been granted patents in Europe, Japan, and Israel for its ALS drug PrimeC. The patents relate to NeuroSense's unique fixed-dose combination of ciprofloxacin and celecoxib, the active ingredients in PrimeC. Corresponding patents have been issued in the U.S., Canada, and Australia and are valid through 2038. Clinical topline results from Phase 2b ALS trial are expected in H2 2023.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:08 pm

PULM

Pulmatrix has received FDA approval for its Investigational New Drug (IND) application for PUR3100, a treatment for acute migraine. The company has also received a 'study may proceed' letter for a Phase 2 study of the drug.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:06 pm

GOVX

GeoVax Labs, Inc. (NASDAQ:GOVX) has published data from the ongoing Phase 2 trial of its next-generation COVID-19 vaccine (GEO-CM04S1), demonstrating potent antibody and cellular immunity in immunocompromised patients. The vaccine is being compared to the Pfizer/BioNTech or Moderna mRNA-based vaccines in patients with compromised immune systems. The data indicates that GEO-CM04S1 is highly immunogenic in these patients, inducing potent humoral (antibody) and cellular (T cell) responses, including neutralizing antibodies against SARS-CoV-2 ancestral virus and variants of concern.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:06 pm

MTTR

PCOR

Matterport, Inc. (NASDAQ:MTTR) has announced an expanded collaboration with Procore Technologies Inc. (NYSE:PCOR), a global provider of construction management software. The collaboration will enhance Matterport's platform ecosystem support for design and construction management software services. Procore users can now use features such as RFI's, Observations, and Coordination Issues directly within Matterport's 3D digital twins, creating a visual system-of-record for site conditions. The integration aims to improve project tracking, quality control, and efficiency in closeout processes.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:05 pm

ACIW

MSFT

ACI Worldwide has partnered with Microsoft to speed up the global transition to real-time payments. The ACI Real-Time Payments Cloud Platform, hosted on Microsoft Azure, will assist financial institutions in enabling instant payment transactions more quickly.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:04 pm

SXTP

60 Degrees Pharmaceuticals Inc's subsidiary, 60P Australia Pty Ltd, has withdrawn its investigational new drug application for ACLR8-LR, a Phase 2B study of the use of tafenoquine in treating COVID-19, in response to FDA comments. The company plans to submit a new application in Q4, pending a feasibility assessment of revising the trial design. Meanwhile, 60P has paused further start-up activities for its Phase 2B trial, improving its short-term cash position. The company's shares are down 28.1% in premarket trading.

Portfolio Pulse from Vandana Singh

September 19, 2023 | 1:04 pm

INFA

ORCL

Informatica (NYSE:INFA) and Oracle have strengthened their strategic partnership with the creation of an Oracle Cloud Infrastructure (OCI) point of delivery to thousands of joint customers across North America. The partnership includes new integrations and capabilities for Informatica's Intelligent Data Management Cloud (IDMC) across Oracle's Modern Data Platform. The collaboration aims to deliver clean, secure, trusted data to empower greater AI/ML utilization and accelerate modernization journeys.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:03 pm

GCI

TBLA

Taboola has entered into an exclusive five-year content recommendation partnership with Gannett. As part of the deal, Gannett will test additional Taboola offerings for editorial recommendations on publisher homepages and support Taboola's turnkey consumer product review site.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:03 pm